Actively Recruiting

Phase Not Applicable
Age: 1Year - 16Years
All Genders
ID07210658

Acceptability Including Gastrointestinal Tolerance, Compliance and Palatability of a Pediatric Oral Nutritional Supplement Containing Food Blends

Led by Société des Produits Nestlé (SPN) · Updated on 2026-01-09

25

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate the acceptability of a pediatric oral nutritional supplement containing food blends. It focuses on assessing gastrointestinal tolerance, how well children comply with the supplement, and the palatability of the product. The study includes children aged 1 to 16 years who require nutritional support due to disease-related malnutrition and are stable on their current nutritional regimen. Participants will receive the oral nutritional supplement as directed by their healthcare provider. Children will act as their own control during the study period, which involves monitoring their response to the nutritional product. The study does not include masking or placebo groups and is observational regarding the supplement's acceptability. During the study, researchers will monitor gastrointestinal tolerance daily for the first week and then on days 14, 21, and 28. They will also measure the volume of formula intake over 28 days. The study involves regular assessments to track compliance, tolerance, and palatability, providing a comprehensive understanding of how the supplement is accepted by pediatric patients over the study duration.

CONDITIONS

Brief Title

Acceptability, Gastrointestinal Tolerance, Compliance and Palatability Study.

Who Can Participate

Age: 1Year - 16Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 1 to 15 years requiring one or more oral nutritional supplements to replace current supplements for disease-related malnutrition
  • Patients well-established and stable on their current nutritional support regimen
  • Written informed consent provided by patient or caregiver
Not Eligible

You will not qualify if you...

  • Unsafe swallow
  • Inability to comply with the study protocol, as judged by the investigator
  • Under 1 year of age
  • Patients receiving total parenteral nutrition
  • Known food allergies, including allergies to any ingredients in the supplement
  • Patients with Chronic Kidney Disease stage 3b, 4, 5 or hepatic impairment
  • Participation in another interventional study within 2 weeks prior
  • Patients with known or suspected ileus or mechanical bowel obstruction

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 28 days

Participants take the pediatric oral nutritional supplement containing food blends as directed by their healthcare provider.

Multiple visits during the 28-day period to monitor gastrointestinal tolerance and compliance

Trial Site Locations

Total: 1 location

1

Dietetics

Nottingham, United Kingdom

Actively Recruiting

Loading map...

Research Team

S

Sharan Saduera, BSc (Hons) Dietetics

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Similar Trials

Comparison of the Effectiveness of Paracetamol With Ibuprofe...

Pancreatitis, Acute

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here